Market Research Store

2017 Forecast - Intra-Dialytic Hypotension (IDH) Global Market News, Industry Size, Share, Analysis and Research to 2022

Global Market Research Report on Intra-Dialytic Hypotension (IDH) Market 2016 is a professional and in-depth complete study on the current state of the Intra-Dialytic Hypotension (IDH) worldwide.


Deerfield Beach, FL -- (SBWIRE) -- 04/06/2017 -- Since past few years, Intra-Dialytic Hypotension (IDH) market has gained traction, witnessed vertical growth and this trend is expected to continue during the forecast period. The main reason for this growth is the increasing number of patients suffering from kidney disorders and undergoing dialysis treatment globally. Other drivers for this market are the technological advancements in the medical field. Recent technological trends such as hemodialysis testing devices along with blood pressure monitors are beneficial for patients. Online hematocrit monitoring devices aid in the calculation of plasma volume changes, ultrafiltration, and plasma refill rates (such as UFR, PRR). The mismatch in the plasma refill rates help to interpret the physiology of intra-dialytic hypotension episodes.

Get Free Sample Report Of Intra-Dialytic Hypotension (IDH) Market @

Intra-dialytic hypotension (IDH) is defined as a fall in systolic blood pressure by ?20 mmHg or in mean arterial pressure (MAP) by 10 mmHg correlated with symptoms, which include nausea, abdominal discomfort, yawning, sighing, vomiting, muscle cramps, restlessness, dizziness or fainting, and anxiety. It is the most common complications associated with hemodialysis treatment, which impairs the well-being of patient. Apart from that, it can aggravate cardiac arrhythmias and influence the coronary or result in cerebral ischemic diseases. In addition, the clinical IDH obstructs with an accurate dose delivery of dialysis therapeutics, as hypotension episodes lead to the compartment effect and cause suboptimal Kt/vUrea. Amongst the global population suffering from kidney failure, 76% of dialysis patients are reported to consume anti- hypertensive medications. Intra-dialytic hypotension is observed in 15% of the hemodialysis patients.

Do Inquiry To Buy Report Of Intra-Dialytic Hypotension (IDH) Market @


Hospital devices: instruments and systems
Hemodialysis testing devices along with blood pressure monitors
Continuous hematocrit monitoring devices
POC testing devices: various diagnostic kits and others
Continuous non-invasive arterial pressure monitor (CNAP devices)


Hospital testing
Commercial/private hospitals
Public health hospitals
Home healthcare


North America


Hospitals and research institutes
Pharmaceutical companies
Academic institutes

Contact Us:
Joel John
3422 SW 15 Street, Suite #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: 386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 855-465-4651